Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Bon Natural Life (BON) over the last 6 years, with Q3 2025 value amounting to $6.3 million.

  • Bon Natural Life's Cash & Equivalents rose 768711.26% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 768711.26%. This contributed to the annual value of $6.3 million for FY2025, which is 768711.26% up from last year.
  • Per Bon Natural Life's latest filing, its Cash & Equivalents stood at $6.3 million for Q3 2025, which was up 768711.26% from $6.3 million recorded in Q1 2025.
  • Bon Natural Life's Cash & Equivalents' 5-year high stood at $6.3 million during Q1 2025, with a 5-year trough of $80466.0 in Q3 2024.
  • For the 5-year period, Bon Natural Life's Cash & Equivalents averaged around $2.1 million, with its median value being $1.0 million (2021).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 8659.1% in 2023, then skyrocketed by 768711.26% in 2025.
  • Bon Natural Life's Cash & Equivalents (Quarter) stood at $1.9 million in 2021, then crashed by 55.83% to $840861.0 in 2022, then crashed by 86.59% to $112751.0 in 2023, then decreased by 28.63% to $80466.0 in 2024, then soared by 7687.11% to $6.3 million in 2025.
  • Its Cash & Equivalents stands at $6.3 million for Q3 2025, versus $6.3 million for Q1 2025 and $80466.0 for Q3 2024.